European Innovation Council is a European Union initiative established in 2018 to support deep-technology innovation and help startups, researchers, and small companies scale. It offers funding opportunities and business acceleration services, and engages in co-investment with private investors in early-stage ventures with ESG impact. The EIC emphasizes female entrepreneurship through programs such as Women TechEU and related awards, and provides resources to promote knowledge sharing and community building. Based in Brussels, it pursues a European-wide mandate to strengthen Europe's position in the global deep-tech ecosystem.

Climb Ventures is a Swiss venture capital firm founded in 2020 and based in Geneva. It backs technology-focused startups across Europe, investing in sectors such as information technology, IoT, advanced manufacturing, fintech, AR, clean tech, e-commerce, gaming, and agtech, with particular attention to Swiss companies pursuing global scale. The firm provides capital, strategic guidance, and access to industry networks to accelerate growth and international expansion, including AI, renewable energy, and digital transformation. Climb targets founders with global ambitions and supports growth to late-stage across digital services, consumer internet, and emerging technologies, leveraging a European footprint to drive market penetration.

French Partners is a venture capital firm and co-investment club dedicated to funding and supporting French-led companies on their international growth. It targets startups and growing SMEs with revenues up to tens of millions of euros, as well as innovative investment funds seeking to accelerate their international presence. The firm typically invests from €1 million to €5 million, often on a minority basis, either alone or in co-investment, in companies founded and managed by French entrepreneurs abroad. Founded in 2016 and headquartered in Geneva, Switzerland, French Partners concentrates on early-stage opportunities and cross-border expansion.

4See Ventures is a Swiss venture capital firm based in Geneva that backs early-stage startups in healthcare, biotech, medtech, technology, sustainability and climate tech. Founded in 2019, the firm concentrates on Swiss ventures with game-changing potential, emphasizing disruptive innovation, market insight, and anticipation of future trends. It supports entrepreneurs who drive societal impact and transformation, and has invested in companies such as Haya Therapeutics, Transmutex, Distalmotion, and Goodwall.

Tayssir Capital is a Geneva-based venture capital firm, established in 2021, that specializes in digital assets investments. The company focuses on identifying and funding opportunities in the digital asset space from its Geneva base, aiming to support early-stage and growth ventures with capital and strategic guidance.

Founded in 2019 and based in Geneva, Switzerland, Olive Capital is an angel network that provides its members access to investment opportunities in innovative, early-stage companies. Focusing primarily on the web3 sector, they leverage a deep global network of entrepreneurs to offer unique investment prospects.

Vinci Capital is a Swiss venture capital and private equity firm focused on mid to late venture, succession financing, owner- and management buyouts, spin-offs or carve-outs, and secondary share-backs. It invests in Swiss technology and industrial companies, typically committing CHF 7–10 million per portfolio and targeting firms with annual sales of roughly CHF 20–80 million. The firm seeks opportunities in new media technologies and services, life sciences, microelectronics and nanotechnology, and software and e-Business, and it often takes board seats and can syndicate larger rounds. Founded in 2003 and headquartered in Geneva with an office in Zug, Vinci Capital operates as a subsidiary of Vinci Partners.

Alpana Ventures is a Swiss venture capital firm based in Geneva that focuses on digital transformation and deeptech investments across Europe, North America and Asia-Pacific. Founded in 2016, it supports seed to growth-stage companies by helping embed breakthrough technologies into innovative business models to create lasting value and global market leadership. The firm applies ESG criteria in its investment approach and seeks opportunities across sectors such as healthcare, information technology, finance, enterprise solutions, mobility, cybersecurity, gaming and related fields. It emphasizes sustainability and Cleantech as part of its digital transformation focus and collaborates with entrepreneurs to scale global operations.

VI Partners is a Swiss venture capital firm founded in 2001 and based in Altendorf. It focuses on investments in healthcare, biotechnology, technology and software companies across Switzerland and Europe, including university spin-offs and other promising startups. The firm provides capital, strategic guidance and access to an extensive network to support portfolio companies as they grow, particularly in early stages such as Seed and Series A rounds. With deep sector expertise and experience in board and shareholder discussions, VI Partners aims to contribute to long-term value creation for its portfolio companies.

DART Ventures is a Zurich-based venture capital firm that backs early-stage startups in health and climate technologies across the United States and Europe. It invests in B2B, health technology, health consumer tech, food tech, clean tech, and climate tech ventures, with a focus on patient-centric AI, decarbonization, and energy transition. The firm runs a 12-month tailored expansion program that provides strategic guidance on growth, culture, fundraising, and go-to-market, leveraging experienced partners and networks to help portfolio companies expand in the US. DART Ventures emphasizes founder alignment of purpose and profit and seeks to connect portfolio companies with US investors and board members to support scale.

Omega Funds is a Boston, Massachusetts-based venture capital firm focused on life sciences and healthcare investments across North America and Western Europe. The firm targets opportunities in the life sciences, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service, leveraging an experienced team and broad network to support entrepreneurs and founders. It has facilitated the development of products reaching patients and has a track record that includes a public listing and an M&A deal. The firm operates across multiple funds and engages with the European ecosystem, sharing insights through publications such as the Omega Insights Series.

CDP Venture Capital is a leading Italian venture capital fund manager with about €4.9 billion in assets under management across 15 direct and indirect funds, investing to accelerate strategic sectors and sustain Italian growth within a broad ecosystem that includes a national accelerator network and the XJOBS job board. The group operates from Rome and Milan and concentrates on sustainability, entrepreneurship, and responsible value creation for the Italian market, publishing annual financial reviews and supporting portfolio companies through strategic partnerships and new vehicles; notable milestones include the appointment of Emanuele Levi as Chief Executive and General Manager, a strategic partnership with TIM to generate industrial, commercial, and technological synergies, and the launch of Lumen II, a seed-stage vehicle focused on insurtech, fintech, digital health and cybersecurity. The portfolio activity is evidenced by ISAAC's €14 million funding round, underscoring portfolio maturity.

Syncona is a London-based venture capital and investment firm focused on building global leaders in life sciences. It provides long-term capital to healthcare companies across startup to established stages, with emphasis on gene therapy, targeted cell therapy, and advanced diagnostics. The firm adopts a global investment approach and typically allocates between £1 million and £20 million per company, supporting both majority and syndicated investments. Its portfolio centers on transformative treatments for areas of high unmet medical need, aiming to turn scientific breakthroughs into clinically meaningful products and durable value for patients and shareholders. Syncona collaborates with leading scientists and aligns with major science funders to advance its mission.

Amboy Street Ventures is a venture capital firm that concentrates on women’s health and sexual wellbeing startups. Founded in 2021 and based in Los Angeles, the firm focuses on early-stage investments, including seed and Series A rounds, with a geographic scope spanning the United States and Europe. It backs companies developing fertility, sexual health, and broader women’s health technologies across multiple sub-segments, such as menopause, maternal health, LGBTQ+ health, menstrual health, hormonal health, and sexual wellness. Portfolio areas include products and services ranging from vaginal microbiome testing and male contraception to at‑home insemination kits, digital abortion care, and telehealth services. The firm positions itself to support innovative startups addressing unmet needs in women’s health and sexual wellbeing, aiming to advance access and care for diverse populations.

Gaingels is a venture investment syndicate focused on supporting LGBTQ founders and inclusive leadership by investing across stages and partnering with other venture firms to back diverse, high-potential companies. It maintains a global portfolio of 130+ companies and has deployed tens of millions in capital to date. The organization actively helps portfolio companies identify and recruit diverse talent for C-suite and board roles and cultivates a worldwide network of investors, operators, and entrepreneurs who share a commitment to positive social change through business.

LIFTT is a European venture capital holding focused on deep tech, seeking to transform excellent scientific research into high-impact ventures and accelerate the journey from lab to market. It pursues a multi-vertical investment approach across Critical Resources, Human Health and Aging, Infrastructure for Data Revolution, Energy Security and Industrial Automation, reflecting a holistic view of technology ecosystems. Based in Turin, Italy, LIFTT emphasizes a governance framework centered on ethics and sustainable growth, and actively connects ideas, talent, territories and financial resources to catalyze innovation.

OCCIDENT is a Munich-based venture capital firm that backs deep-tech start-ups, with a focus on spin-offs from scientific research. The firm invests its own capital from the seed stage and maintains a long-term, hands-on approach, providing financial support and operational guidance to portfolio companies in life sciences and industrial tech from early development onward. With offices in Munich and Zug, OCCIDENT aims to create sustainable value and a positive societal impact through its investments by partnering closely with founders to translate scientific advances into practical solutions.

Panakes Partners is an independent venture capital firm based in Milan, Italy, that focuses on early-stage investments in life sciences and healthcare companies across Europe and Israel. It provides capital and hands-on support to entrepreneurs and scientific teams, leveraging a network of clinicians and industry experts to help portfolio companies advance products and reach clinical and commercial milestones. The firm’s activity spans dermatology, oncology, cardiovascular disease, and neurology, and it emphasizes sustainable impact through ESG principles and adherence to broader European innovation programs.

EMURGO drives the adoption of Cardano by building, investing in, and advising projects that adopt Cardano’s decentralized blockchain ecosystem. It leverages its blockchain R&D expertise and a global partner network to support ventures worldwide and collaborates with Cardano project partners to grow Cardano’s ecosystem and promote adoption. The company develops blockchain and smart contract technology and provides end-to-end website and mobile application development, IT consulting, and digital marketing services for developers, startups, enterprises, and governments from ideation to post-production support. It pursues asset tokenization and fintech solutions to bridge traditional finance and Web3, enabling businesses and users to access tokenized assets and services. EMURGO also offers workshops and thought leadership content to educate the industry and broaden adoption of Cardano’s technology.

Spicehaus Partners is a Swiss venture capital firm focused on early-stage technology investments in Switzerland, with a particular emphasis on B2B software. Based in Zug, the firm acts as lead investor and partners with portfolio companies to drive growth and digital transformation. It has funded more than 40 companies and has achieved notable exits such as MOVU and Bexio, while backing investments in fintech, proptech, and cybersecurity. The firm combines investment expertise with entrepreneurial experience to support startups on their path to international success and job creation in the Swiss tech ecosystem.

Innovationsstiftung der SZKB is a venture capital investor established in 2006 and based in Schwyz, Switzerland. It finances early-stage technology companies across Switzerland, focusing on software, SaaS, enterprise, and consumer software sectors. It has supported Swiss startups as a lead investor in first-round financings and has a reported capital base of CHF 20 million. The entity operates with investment decisions that are independent of SZKB while maintaining ties to the group, and concentrates on helping young technology companies achieve growth in the Swiss market.

NEXT VENTŪRES is a venture capital firm founded in 2018 and located in Austin, Texas. The firm specializes in investments within the sports, fitness, nutrition, and wellness sectors. With a team that possesses extensive expertise and strong industry connections, NEXT VENTŪRES is equipped to generate substantial value for both its investors and portfolio companies.

ACE & Company is a global private equity and venture capital firm founded in 2005. It operates two core lines: venture capital focused on early to late-stage technology and private equity concentrating on lower mid-market buyouts and secondary investments. The firm pursues diversified, risk-adjusted private capital strategies and supports independent governance through investment and valuation committees. It maintains a global footprint with offices in Geneva, Zurich, New York, London, and Cairo and collaborates with external partners to provide investment solutions. ACE emphasizes a sector- and region-agnostic approach.

LGT Capital Partners is a Swiss-based alternative investment manager, headquartered in Pfäffikon with a Zurich base and offices globally, that focuses on private markets and multi-asset solutions. It offers investments across private equity, real estate, hedge funds, and private credit, including buyouts, venture capital, growth finance, mezzanine financing, and special situations, alongside liquid alternatives and multi-strategy approaches. The firm serves institutional clients such as pension funds, sovereign wealth funds, insurers, foundations, endowments and banks worldwide, and employs a rigorous, bottom-up investment process to select managers and opportunities across public and private markets.

TeleSoft Partners is a United States-based venture capital firm focused on technology and energy value chain companies in North America. Founded in 1996, the firm provides capital and guidance to entrepreneurs, drawing on knowledge, contacts and experience to support growth. It has a track record of helping build more than 75 companies, with over 50 exits through acquisition or initial public offering, and invests across software, IT solutions and related TMT sectors.

Paradigm is a research-driven technology investment firm based in San Francisco that funds and builds in crypto, AI, robotics, and other frontier technologies. Founded in 2018, it supports unconventional founders at every stage and combines deep technical research with hands-on development alongside teams shaping the frontier. The firm backs category-defining crypto protocols and software projects that reshape how people transact, build, and compute, and it promotes open-source collaboration through programs that engage builders from the ground up.

Section 32 is a California-based venture capital firm founded in 2017 and headquartered in Silicon Valley. It concentrates on early‑stage technology, software, data, AI, enterprise software, cybersecurity, quantum computing, computational biology, biotechnology, life sciences, and healthcare companies across the United States. Founded by Bill Maris, the firm pursues a capital‑constrained, hands‑on investment approach, reserving substantial resources for a small number of companies and offering active support in areas such as talent acquisition and execution. Section 32 seeks founders building iconic, frontier‑level technology companies that can broadly improve the human condition.

Nauta Capital is a pan-European venture capital firm that backs early-stage B2B software companies. Founded in 2004 and headquartered in London, it maintains offices in Barcelona and Munich. The firm focuses on Series A, late seed, and Series B investments in technology companies across sectors such as B2B software, fintech, insurtech, health tech, retail tech, and enterprise software, including AI, machine learning, and deep-tech applications. Its portfolio targets startups with strong product-market fit and scalable business models across Europe.

TPY Capital is a Tel Aviv-based venture capital firm that backs Israeli technology companies across early-stage to growth stages. The firm focuses on sectors including data and analytics, digitization, human augmentation, fintech, cloud infrastructure, enterprise software, and frontier technologies such as quantum computing. TPY Capital typically leads rounds in its target areas and prefers minority positions, while providing hands-on support through high-level strategy and practical execution assistance. Its approach emphasizes close collaboration with founders to accelerate growth, offering talent, feedback, and operational guidance and building a networked portfolio community of innovators. The firm invests in pre-revenue and revenue-stage startups and aims to help portfolio companies scale globally from its Israel base.

Valuta Capital Partners is a global advisory and investment firm headquartered in Istanbul, established in 2005. It provides management consulting and investment solutions to businesses and families, with a Dubai presence. The firm supports SMEs and startups through direct investments and co-investments, as well as pre-deal financial advisory, M&A support, financing solutions, and wealth preservation guidance. Drawing on a network of international investors and service providers, Valuta Capital Partners emphasizes strategic know-how, disciplined project management, and long-term partnerships, aiming to understand each client's needs and deliver sustainable value. The organization prioritizes industry expertise and a personal touch, supported by an external advisory board of industry leaders.

ProQuest Investments is a healthcare venture capital firm founded in 1998 that provides seed to late-stage financing to healthcare and biotechnology companies. The firm manages over $875 million in capital and operates offices in Princeton, San Diego, and Montreal. It has a focus on therapeutics and has investments across oncology, pain, and infectious disease, seeking long-term partnerships with entrepreneurs.